Globus Medical (GMED) Cash from Investing Activities Growth (1y) (2012 - 2026)
Analysis
Globus Medical (GMED) Cash from Investing Activities Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 0.00% |
| 10 | Globus Medical | 10.01 Bn | 9.42 Bn | 548.17 Mn | 56.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.86% |
| Mar 31, 2026 | -239.04% |
| Dec 31, 2025 | -7.04% |
| Sep 30, 2025 | -406.73% |
| Jun 30, 2025 | -2,782.14% |
| Mar 31, 2025 | 382.04% |
| Dec 31, 2024 | -132.48% |
| Sep 30, 2024 | 81.49% |
| Jun 30, 2024 | -119.87% |
| Mar 31, 2024 | -523.80% |
| Dec 31, 2023 | 630.08% |
| Sep 30, 2023 | -28.13% |
| Jun 30, 2023 | 92.52% |
| Mar 31, 2023 | 179.11% |
| Dec 31, 2022 | 75.19% |
| Sep 30, 2022 | -816.63% |
| Jun 30, 2022 | 19,069.23% |
| Mar 31, 2022 | 88.89% |
| Dec 31, 2021 | -104.71% |
| Sep 30, 2021 | -189.87% |